Literature DB >> 8018130

Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature.

H C Farrar1, M C Walsh-Sukys, K Kyllonen, J L Blumer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8018130     DOI： 10.1097/00006454-199308000-00011

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  8 in total

1.  Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants.

Authors:  P C Ng; K W So; K S Fung; C H Lee; T F Fok; E Wong; W Wong; K L Cheung; A F Cheng
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-05       Impact factor: 5.747

Review 2.  Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.

Authors:  N Principi; S Esposito
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

Review 3.  Macrolide antibiotics in paediatric infectious diseases.

Authors:  D R Guay
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

Review 4.  Erythromycin as a prokinetic agent in preterm neonates: a systematic review.

Authors:  S Patole; S Rao; D Doherty
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05-17       Impact factor: 5.747

Review 5.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 6.  Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum.

Authors:  C Bührer; T Hoehn; J Hentschel
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  Antimicrobial susceptibility patterns of Ureaplasma species and Mycoplasma hominis in pregnant women.

Authors:  Mathys J Redelinghuys; Marthie M Ehlers; Andries W Dreyer; Hennie A Lombaard; Marleen M Kock
Journal:  BMC Infect Dis       Date:  2014-03-28       Impact factor: 3.090

8.  High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants.

Authors:  Pak C Ng; Cheuk H Lee; Samuel P S Wong; Hugh S Lam; Flora Y B Liu; King W So; Cheuk Y Lee; Tai F Fok
Journal:  Gastroenterology       Date:  2007-03-24       Impact factor: 22.682
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.